-
1
-
-
0031927984
-
New approach to classifying non-hodgkins lymphomas: Clinical features of the major histologic subtypes. Non-hodgkins lymphoma classification project
-
Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkins lymphomas: clinical features of the major histologic subtypes. Non-Hodgkins Lymphoma Classification Project. J Clin Oncol. 1998;16:2780-95.
-
(1998)
J Clin Oncol
, vol.16
, pp. 2780-2795
-
-
Armitage, J.O.1
Weisenburger, D.D.2
-
2
-
-
9144237554
-
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
-
Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275-82.
-
(2004)
Blood
, vol.103
, pp. 275-282
-
-
Hans, C.P.1
Weisenburger, D.D.2
Greiner, T.C.3
-
3
-
-
57149089307
-
Stromal gene signatures in large-B-cell lymphomas
-
Lenz G, Wright G, Dave SS, et al. Stromal gene signatures in large-B-cell lymphomas. N Engl J Med. 2008;359:2313-23.
-
(2008)
N Engl J Med
, vol.359
, pp. 2313-2323
-
-
Lenz, G.1
Wright, G.2
Dave, S.S.3
-
4
-
-
0027409814
-
Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin lymphoma. Results of a prospective randomized study
-
Yahalom J, Varsos G, Fuks Z, et al. Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin lymphoma. Results of a prospective randomized study. Cancer. 1993;71:2342-50.
-
(1993)
Cancer
, vol.71
, pp. 2342-2350
-
-
Yahalom, J.1
Varsos, G.2
Fuks, Z.3
-
5
-
-
0018717552
-
CVP-remission-maintenance in stage I or II non-Hodgkins lymphomas: Preliminary results of a randomized study
-
Landberg TG, Hakansson LG, Moller TR, et al. CVP-remission-maintenance in stage I or II non-Hodgkins lymphomas: preliminary results of a randomized study. Cancer. 1979;44:831-8.
-
(1979)
Cancer
, vol.44
, pp. 831-838
-
-
Landberg, T.G.1
Hakansson, L.G.2
Moller, T.R.3
-
6
-
-
0018898424
-
Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkins lymphoma
-
Monfardini S, Banfi A, Bonadonna G, et al. Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkins lymphoma. Intl J Rad Oncol Biol Phys. 1980;6:125-34.
-
(1980)
Intl J Rad Oncol Biol Phys
, vol.6
, pp. 125-134
-
-
Monfardini, S.1
Banfi, A.2
Bonadonna, G.3
-
7
-
-
0020619345
-
A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-Hodgkins lymphomas
-
Nissen NI, Ersboll J, Hansen HS, et al. A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-Hodgkins lymphomas. Cancer. 1983;52:1-7.
-
(1983)
Cancer
, vol.52
, pp. 1-7
-
-
Nissen, N.I.1
Ersboll, J.2
Hansen, H.S.3
-
8
-
-
23044503407
-
Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: A study by the groupe detude des lymphomes de ladulte
-
Feugier P, Van Hoof A, Sebban C, et al. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe dEtude des Lymphomes de lAdulte. J Clin Oncol. 2005;23:4117-26.
-
(2005)
J Clin Oncol
, vol.23
, pp. 4117-4126
-
-
Feugier, P.1
Van Hoof, A.2
Sebban, C.3
-
9
-
-
33745982067
-
Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma
-
Habermann TM, Weller EA, Morrison VA, et al. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol. 2006;24:3121-7.
-
(2006)
J Clin Oncol
, vol.24
, pp. 3121-3127
-
-
Habermann, T.M.1
Weller, E.A.2
Morrison, V.A.3
-
10
-
-
0022634894
-
Factors predicting survival in adults with stage I and II large-cell lymphoma treated with primary radiation therapy
-
Kaminski MS, Coleman CN, Colby TV, et al. Factors predicting survival in adults with stage I and II large-cell lymphoma treated with primary radiation therapy. Ann Int Med. 1986;104:747-56.
-
(1986)
Ann Int Med
, vol.104
, pp. 747-756
-
-
Kaminski, M.S.1
Coleman, C.N.2
Colby, T.V.3
-
11
-
-
0028352295
-
Clinical stage 1 non-Hodgkins lymphoma: Long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy
-
Vaughan Hudson B, Vaughan Hudson G, MacLennan KA, et al. Clinical stage 1 non-Hodgkins lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy. Br J Cancer. 1994;69:1088-93.
-
(1994)
Br J Cancer
, vol.69
, pp. 1088-1093
-
-
Vaughan Hudson, B.1
Vaughan Hudson, G.2
MacLennan, K.A.3
-
12
-
-
0018742213
-
Results of radiotherapy in control of stage I and II non-Hodgkins lymphoma
-
Chen MG, Prosnitz LR, Gonzalez-Serva A, Fischer DB. Results of radiotherapy in control of stage I and II non-Hodgkins lymphoma. Cancer. 1979;43:1245-54.
-
(1979)
Cancer
, vol.43
, pp. 1245-1254
-
-
Chen, M.G.1
Prosnitz, L.R.2
Gonzalez-Serva, A.3
Fischer, D.B.4
-
13
-
-
4143102674
-
Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkins lymphoma: Eastern Cooperative Oncology Group study 1484
-
Horning SJ, Weller E, Kim K, et al. Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkins lymphoma: Eastern Cooperative Oncology Group study 1484. J Clin Oncol. 2004;22:3032-8.
-
(2004)
J Clin Oncol
, vol.22
, pp. 3032-3038
-
-
Horning, S.J.1
Weller, E.2
Kim, K.3
-
14
-
-
33947543250
-
CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: A study by the Groupe dEtude des Lymphomes de lAdulte
-
Bonnet C, Fillet G, Mounier N, et al. CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: a study by the Groupe dEtude des Lymphomes de lAdulte. J Clin Oncol. 2007;25:787-92.
-
(2007)
J Clin Oncol
, vol.25
, pp. 787-792
-
-
Bonnet, C.1
Fillet, G.2
Mounier, N.3
-
15
-
-
0032474694
-
Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkins lymphoma
-
Miller TP, Dahlberg S, Cassady JR, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkins lymphoma. N Engl J Med. 1998;339:21-6.
-
(1998)
N Engl J Med
, vol.339
, pp. 21-26
-
-
Miller, T.P.1
Dahlberg, S.2
Cassady, J.R.3
-
16
-
-
0003242248
-
CHOP alone compared to CHOP plus radiotherapy for early stage aggressive non-Hodgkins lymphomas: Update of the Southwest Oncology Group (SWOG) randomized trial
-
Miller TP, LeBlanc M, Spier C. CHOP alone compared to CHOP plus radiotherapy for early stage aggressive non-Hodgkins lymphomas: Update of the Southwest Oncology Group (SWOG) randomized trial. Blood. 2001;98:724.
-
(2001)
Blood
, vol.98
, pp. 724
-
-
Miller, T.P.1
LeBlanc, M.2
Spier, C.3
-
17
-
-
20144369743
-
ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma
-
Reyes F, Lepage E, Ganem G, et al. ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma. N Engl J Med. 2005;352:1197-205.
-
(2005)
N Engl J Med
, vol.352
, pp. 1197-1205
-
-
Reyes, F.1
Lepage, E.2
Ganem, G.3
-
18
-
-
68449101743
-
-
(IELSG 4). [corrected]
-
Martinelli G, Gigli F, Calabrese L, et al. Early stage gastric diffuse large B-cell lymphomas: results of a randomized trial comparing chemotherapy alone versus chemotherapy + involved field radiotherapy. (IELSG 4). [corrected]. Leukem Lymphoma. 2009;50:925-31.
-
(2009)
Leukem Lymphoma
, vol.50
, pp. 925-931
-
-
Martinelli, G.1
Gigli, F.2
Calabrese, L.3
-
19
-
-
44249092120
-
Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014
-
Persky DO, Unger JM, Spier CM, et al. Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014. J Clin Oncol. 2008;26:2258-63.
-
(2008)
J Clin Oncol
, vol.26
, pp. 2258-2263
-
-
Persky, D.O.1
Unger, J.M.2
Spier, C.M.3
-
20
-
-
77957940539
-
Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy
-
Phan J, Mazloom A, Medeiros J, et al. Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy. J Clin Oncol. 2010;28:4170-6.
-
(2010)
J Clin Oncol.
, vol.28
, pp. 4170-4176
-
-
Phan, J.1
Mazloom, A.2
Medeiros, J.3
-
21
-
-
23044453180
-
Role of positron emission tomography in lymphoma
-
Juweid ME, Cheson BD. Role of positron emission tomography in lymphoma. J Clin Oncol. 2005;23:4577-80.
-
(2005)
J Clin Oncol
, vol.23
, pp. 4577-4580
-
-
Juweid, M.E.1
Cheson, B.D.2
-
22
-
-
24044553298
-
FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma
-
Mikhaeel NG, Hutchings M, Fields PA, et al. FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma. Ann Oncol. 2005;16:1514-23.
-
(2005)
Ann Oncol
, vol.16
, pp. 1514-1523
-
-
Mikhaeel, N.G.1
Hutchings, M.2
Fields, P.A.3
-
23
-
-
0035863387
-
Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkins lymphoma: Is [18F] FDG-PET a valid alternative to conventional diagnostic methods?
-
Spaepen K, Stroobants S, Dupont P, et al. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkins lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods? J Clin Oncol. 2001;19:414-9.
-
(2001)
J Clin Oncol
, vol.19
, pp. 414-419
-
-
Spaepen, K.1
Stroobants, S.2
Dupont, P.3
-
24
-
-
78650763342
-
Positive PET prior to consolidative radiation therapy increases risk of in-field failure in diffuse large B-cell lymphoma
-
Dorth J, Chino J, Prosnitz L, Kelsey C. Positive PET prior to consolidative radiation therapy increases risk of in-field failure in diffuse large B-cell lymphoma. Proceedings of ASTRO; IJROBP. 2009;75:S64.
-
(2009)
Proceedings of ASTRO; IJROBP
, vol.75
-
-
Dorth, J.1
Chino, J.2
Prosnitz, L.3
Kelsey, C.4
-
25
-
-
0025338858
-
Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas
-
Lavey RS, Eby NL, Prosnitz LR. Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas. Cancer. 1990;66:80-8.
-
(1990)
Cancer
, vol.66
, pp. 80-88
-
-
Lavey, R.S.1
Eby, N.L.2
Prosnitz, L.R.3
-
26
-
-
24944474897
-
Second primary malignancies after treatment for malignant lymphoma
-
Okines A, Thomson CS, Radstone CR, et al. Second primary malignancies after treatment for malignant lymphoma. Br J Cancer. 2005;93:418-24.
-
(2005)
Br J Cancer
, vol.93
, pp. 418-424
-
-
Okines, A.1
Thomson, C.S.2
Radstone, C.R.3
-
27
-
-
0027394689
-
Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkins lymphoma
-
Fisher RI, Gaynor ER, Dahlberg S, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkins lymphoma. N Engl J Med. 1993;328:1002-6.
-
(1993)
N Engl J Med
, vol.328
, pp. 1002-1006
-
-
Fisher, R.I.1
Gaynor, E.R.2
Dahlberg, S.3
-
28
-
-
0030973746
-
High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma
-
Gianni AM, Bregni M, Siena S, et al. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N Engl J Med. 1997;336:1290-7.
-
(1997)
N Engl J Med
, vol.336
, pp. 1290-1297
-
-
Gianni, A.M.1
Bregni, M.2
Siena, S.3
-
29
-
-
0028062747
-
Adjuvant radiotherapy to sites of previous bulky disease in patients stage IV diffuse large cell lymphoma
-
Aviles A, Delgado S, Nambo MJ, et al. Adjuvant radiotherapy to sites of previous bulky disease in patients stage IV diffuse large cell lymphoma. Intl J Rad Oncol Biol Phys. 1994;30:799-803.
-
(1994)
Intl J Rad Oncol Biol Phys
, vol.30
, pp. 799-803
-
-
Aviles, A.1
Delgado, S.2
Nambo, M.J.3
-
30
-
-
2542555752
-
Adjuvant radiotherapy in stage IV diffuse large cell lymphoma improves outcome
-
Aviles A, Fernandezb R, Perez F, et al. Adjuvant radiotherapy in stage IV diffuse large cell lymphoma improves outcome. Leukem Lymphoma. 2004;45:1385-9.
-
(2004)
Leukem Lymphoma
, vol.45
, pp. 1385-1389
-
-
Aviles, A.1
Fernandezb, R.2
Perez, F.3
-
31
-
-
0034110840
-
Consolidation radiotherapy to bulky or semibulky lesions in the management of stage III-IV diffuse large B cell lymphomas
-
Ferreri AJ, DellOro S, Reni M, et al. Consolidation radiotherapy to bulky or semibulky lesions in the management of stage III-IV diffuse large B cell lymphomas. Oncol. 2000;58:219-26.
-
(2000)
Oncol
, vol.58
, pp. 219-226
-
-
Ferreri, A.J.1
DellOro, S.2
Reni, M.3
-
32
-
-
0034333172
-
Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas
-
Schlembach PJ, Wilder RB, Tucker SL, et al. Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas. Intl J Rad Oncol Biol Phys. 2000;48:1107-10.
-
(2000)
Intl J Rad Oncol Biol Phys
, vol.48
, pp. 1107-1110
-
-
Schlembach, P.J.1
Wilder, R.B.2
Tucker, S.L.3
-
34
-
-
33947512956
-
Use of positron emission tomography for response assessment of lymphoma: Consensus of the imaging subcommittee of international harmonization project in lymphoma
-
Juweid ME, Stroobants S, Hoekstra OS, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol. 2007;25:571-8.
-
(2007)
J Clin Oncol
, vol.25
, pp. 571-578
-
-
Juweid, M.E.1
Stroobants, S.2
Hoekstra, O.S.3
-
35
-
-
0028790440
-
Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkins lymphoma
-
Philip T, Guglielmi C, Hagenbeek A, et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkins lymphoma. N Engl J Med. 1995;333:1540-5.
-
(1995)
N Engl J Med
, vol.333
, pp. 1540-1545
-
-
Philip, T.1
Guglielmi, C.2
Hagenbeek, A.3
-
36
-
-
77950579581
-
Involved field radiation after autologous stem cell transplant for diffuse large B-cell lymphoma in the rituximab era
-
Biswas T, Dhakal S, Chen R, et al. Involved field radiation after autologous stem cell transplant for diffuse large B-cell lymphoma in the rituximab era. Intl J Rad Oncol Biol Phys.77:79-85.
-
Intl J Rad Oncol Biol Phys
, vol.77
, pp. 79-85
-
-
Biswas, T.1
Dhakal, S.2
Chen, R.3
-
37
-
-
67649884048
-
The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell lymphoma
-
Hoppe BS, Moskowitz CH, Zhang Z, et al. The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell lymphoma. Bone Marrow Transplant. 2009;43:941-8.
-
(2009)
Bone Marrow Transplant
, vol.43
, pp. 941-948
-
-
Hoppe, B.S.1
Moskowitz, C.H.2
Zhang, Z.3
-
38
-
-
0030986405
-
High dose chemotherapy and stem cell rescue for aggressive non-Hodgkins lymphoma: Pattern of failure and implications for involved-field radiotherapy
-
Mundt AJ, Williams SF, Hallahan D. High dose chemotherapy and stem cell rescue for aggressive non-Hodgkins lymphoma: pattern of failure and implications for involved-field radiotherapy. Intl J Rad Oncol Biol Phys. 1997;39:617-25.
-
(1997)
Intl J Rad Oncol Biol Phys
, vol.39
, pp. 617-625
-
-
Mundt, A.J.1
Williams, S.F.2
Hallahan, D.3
-
39
-
-
17144438222
-
Autotransplantation for relapsed or refractory non-Hodgkins lymphoma (NHL): Long-term follow-up and analysis of prognostic factors
-
Rapoport AP, Lifton R, Constine LS, et al. Autotransplantation for relapsed or refractory non-Hodgkins lymphoma (NHL): long-term follow-up and analysis of prognostic factors. Bone Marrow Transplant. 1997;19:883-90.
-
(1997)
Bone Marrow Transplant
, vol.19
, pp. 883-890
-
-
Rapoport, A.P.1
Lifton, R.2
Constine, L.S.3
-
40
-
-
46749092108
-
Consolidative involved field radiotherapy after high dose chemotherapy and autologous stem cell transplantation for non-Hodgkins lymphoma: A case-control study
-
Oehler-Janne C, Taverna C, Stanek N, et al. Consolidative involved field radiotherapy after high dose chemotherapy and autologous stem cell transplantation for non-Hodgkins lymphoma: a case-control study. Hematol Oncol. 2008;26:82-90.
-
(2008)
Hematol Oncol
, vol.26
, pp. 82-90
-
-
Oehler-Janne, C.1
Taverna, C.2
Stanek, N.3
-
41
-
-
23644439927
-
Effective palliation by low dose local radiotherapy for recurrent and/or chemotherapy refractory non-follicular lymphoma patients
-
Haas RL, Poortmans P, de Jong D, et al. Effective palliation by low dose local radiotherapy for recurrent and/or chemotherapy refractory non-follicular lymphoma patients. Eur J Cancer. 2005;41:1724-30.
-
(2005)
Eur J Cancer
, vol.41
, pp. 1724-1730
-
-
Haas, R.L.1
Poortmans, P.2
De Jong, D.3
-
42
-
-
60849120820
-
Efficacy of palliative low-dose involved-field radiation therapy in advanced lymphoma: A phase II study
-
Murthy V, Thomas K, Foo K, et al. Efficacy of palliative low-dose involved-field radiation therapy in advanced lymphoma: a phase II study. Clin Lymphoma Myeloma. 2008;8:241-5.
-
(2008)
Clin Lymphoma Myeloma
, vol.8
, pp. 241-245
-
-
Murthy, V.1
Thomas, K.2
Foo, K.3
-
43
-
-
0035863505
-
Autologous transplantation for diffuse aggressive non-hodgkins lymphoma in patients never achieving remission: A report from the autologous blood and marrow transplant registry
-
Vose JM, Zhang MJ, Rowlings PA, et al. Autologous transplantation for diffuse aggressive non-Hodgkins lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. J Clin Oncol. 2001;19:406-13.
-
(2001)
J Clin Oncol
, vol.19
, pp. 406-413
-
-
Vose, J.M.1
Zhang, M.J.2
Rowlings, P.A.3
-
44
-
-
0034785277
-
The impact of external beam radiation therapy prior to autologous bone marrow transplantation in patients with non-Hodgkins lymphoma
-
Friedberg JW, Neuberg D, Monson E, et al. The impact of external beam radiation therapy prior to autologous bone marrow transplantation in patients with non-Hodgkins lymphoma. Biol Blood Marrow Transplant. 2001;7:446-53.
-
(2001)
Biol Blood Marrow Transplant
, vol.7
, pp. 446-453
-
-
Friedberg, J.W.1
Neuberg, D.2
Monson, E.3
-
45
-
-
34147135138
-
The impact of involved field radiation therapy in the treatment of relapsed or refractory non-Hodgkin lymphoma with high-dose chemotherapy followed by hematopoietic progenitor cell transplant
-
Wendland MM, Smith DC, Boucher KM, et al. The impact of involved field radiation therapy in the treatment of relapsed or refractory non-Hodgkin lymphoma with high-dose chemotherapy followed by hematopoietic progenitor cell transplant. Am J Clin Oncol. 2007;30:156-62.
-
(2007)
Am J Clin Oncol
, vol.30
, pp. 156-162
-
-
Wendland, M.M.1
Smith, D.C.2
Boucher, K.M.3
-
46
-
-
0034307538
-
High-dose chemoradiotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non-Hodgkin lymphoma: An intention-to-treat analysis
-
Kewalramani T, Zelenetz AD, Hedrick EE, et al. High-dose chemoradiotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non-Hodgkin lymphoma: an intention-to-treat analysis. Blood. 2000;96:2399-404.
-
(2000)
Blood
, vol.96
, pp. 2399-2404
-
-
Kewalramani, T.1
Zelenetz, A.D.2
Hedrick, E.E.3
|